Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan

Clicks: 278
ID: 112650
2019
Our results present the current clinical preferences of anti-VEGF treatment for DME in Japan. The best-corrected visual acuity and the retinal thickness are important indicators to institute this therapy. The majority of the ophthalmologists use anti-VEGF treatment as first-line therapy and prefer t …
Reference Key
m2019journalclinical Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sugimoto M;Tsukitome H;Okamoto F;Oshika T;Ueda T;Niki M;Mitamura Y;Ishikawa H;Gomi F;Kitano S;Noma H;Shimura M;Sonoda S;Sawada O;Ohji M;Harimoto K;Takeuchi M;Takamura Y;Kondo M;Sakamoto T;;
Journal journal of diabetes investigation
Year 2019
DOI DOI not found
URL
https://www.pubmed.gov/30204303/
Keywords
disease management National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine prognosis Cross-Sectional Studies follow-up studies Receptors practice patterns pmid:30204303 pmc6400162 doi:10.1111/jdi.12929 masahiko sugimoto hideyuki tsukitome taiji sakamoto angiogenesis inhibitors / administration & dosage* clinical competence diabetic retinopathy / drug therapy* intravitreal injections macular edema / drug therapy* ophthalmologists / statistics & numerical data physicians' / statistics & numerical data* ranibizumab / administration & dosage* vascular endothelial growth factor / administration & dosage* recombinant fusion proteins / administration & dosage* vascular endothelial growth factor a / antagonists & inhibitors*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.